title: Endovascular treatment for superior vena cava obstruction in Behçet disease.
abstract: Behçet disease is a heterogeneous, multisystem inflammatory disorder; vascular involvement has been considered to result from systemic vasculitis, which most frequently affects veins and occurs in 5% to 10% of these patients. However, superior vena cava (SVC) involvement is rare; it accounts for only 6% of the cases. The aim of this article is to a report on a case of SVC recanalization through the use of fibrinolysis and self-expanding stents as treatment of life-threatening SVC syndrome in a young male patient with Behçet disease.
authors.affiliation: Post-Graduate School in Vascular Surgery, Department of Surgery, University of Insubria, viale Borri 57, Varese 21100, Italy.
authors.forename: Patrizio
authors.initials: P
authors.lastname: Castelli
authors.forename: Roberto
authors.initials: R
authors.lastname: Caronno
authors.forename: Gabriele
authors.initials: G
authors.lastname: Piffaretti
authors.forename: Matteo
authors.initials: M
authors.lastname: Tozzi
authors.forename: Chiara
authors.initials: C
authors.lastname: Lomazzi
authors.forename: Domenico
authors.initials: D
authors.lastname: Laganà
authors.forename: Gianpaolo
authors.initials: G
authors.lastname: Carrafiello
authors.forename: Salvatore
authors.initials: S
authors.lastname: Cuffari
mesh_terms: D000328:Adult; D001528:Behcet Syndrome / Q000150:complications* / Q000628:therapy; D002404:Catheterization; D006801:Humans; D008297:Male; D010960:Plasminogen Activators / Q000627:therapeutic use; D011859:Radiography; D015607:Stents; D013479:Superior Vena Cava Syndrome / Q000000981:diagnostic imaging / Q000209:etiology / Q000628:therapy*; D015912:Thrombolytic Therapy; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
chemical_list: D010960:Plasminogen Activators; D014568:Urokinase-Type Plasminogen Activator